BioSpace News Archive

A substantial new documentary film released online to audiences in the UK and across Europe this week, questions claims made by UK, Danish and Spanish health authorities that widespread administering of the HPV vaccine is both safe and a guaranteed means of preventing cervical cancer.

Sareum Holdings plc has today reported new preclinical data that support its ongoing clinical trial with SRA737 as a monotherapy in ovarian cancer.

Commercial Operations Leaders Meet to Sort Fact from Fiction

The highly successful twenty-fourth annual BIO-Europe® international partnering conference wrapped up in Copenhagen, Denmark, last week with a record-breaking 4,200+ attendees from the life sciences who engaged in over 26,000 one-to-one partnering meetings vying for 3,145 licensing opportunities on offer.

AbbVie could be eyeing another potential billion dollars of annual revenue following the accelerated approval of Venclexta for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are age 75 years or older or who cannot tolerate intensive chemotherapy.

Peer review has a long history behind it, and it has since become synonymous with the scientific method. Ever since its original inception in the 18th century, the peer review process has undergone many changes in its evolution to what it is now.

MilliporeSigma, a subsidiary of Merck KGaA, Darmstadt, Germany, handed out $30,000 to three graduate students for their research projects.

The solution integrates with existing MRI scanners and leverages Artificial Intelligence and Machine Learning to complete a comprehensive ischemia exam in less than 15 minutes

If approved, BHV-0223 would become the only formulation of riluzole that does not require swallowing tablets or liquids, offering an important delivery alternative for the standard-of-care treatment of ALS

Technavio analysts forecast the global probiotic drinks market to grow at a CAGR close to 7% during the forecast period, according to their latest market research report.